Tags:CareCenterDiagnosticsHardwareInfrastructureITMedTechPlatformTechnologyUniversity
Enzyre is a UMC St. Radboud spin-off company which officially started in March 2017. It was founded with the mission to develop innovative diagnostic solutions to enable personalized medicine. The company holds the vision to create a point of care (POC) diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.
Location: Netherlands, Gelderland, Nijmegen
Member count: 11-50
Total raised: $13.529646M
Founded date: 2016

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
04.11.2022Series A$11.881917...-vcbay.news...
27.07.2020-$1.647729M-finsmes.co...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
04.11.2022Enzyre clo... Funds will be used to accele...--noval.is/n...
04.11.2022i&i Bi...Firma Enzyre je šestou společn...--einpresswi...
03.11.2022Dutch-base...Nijmegen, the Netherlands-base...Dutch Star...Editorial ...siliconcan...
03.11.2022Netherland...NIJMEGEN, the Netherlands, Nov...--vcbay.news...
02.11.2022Enzyre Clo...Enzyre, a Nijmegen, Netherland...Netherland...-finsmes.co...
28.07.2020This Dutch...Based out of Nijmegen, The Net...Dutch Star...Editorial ...siliconcan...
27.07.2020Enzyre Rec...Enzyre, a Nijmegen, The Nether...Netherland...-finsmes.co...
-Enzyre“Enzyre - Near Patient Diagnos...--fastfounde...